PulseAugur
EN
LIVE 16:12:18
ENTITY ST Wentai

ST Wentai

PulseAugur coverage of ST Wentai — every cluster mentioning ST Wentai across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
0
4 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-05-22 controversy ST Wentai filed a lawsuit seeking 8 billion RMB in damages against Anshi Holdings and others for alleged unlawful execution of discriminatory measures. source
RECENT · PAGE 1/1 · 4 TOTAL
  1. COMMENTARY · CL_52137 ·

    ST Wentai proposes lowering convertible bond price; Kere Tech stock fluctuates

    ST Wentai's board of directors has proposed to lower the conversion price of its convertible bonds, "Wentai Convertible Bonds." This move aims to support the company's long-term development and protect investor interest…

  2. TOOL · CL_49246 ·

    ST WenTai controlling shareholder's shares frozen due to dispute

    ST WenTai announced that its controlling shareholder, Wen Tianxia, had all of its 154 million shares, representing 12.37% of the company's total share capital, judicially frozen. This freeze, effective from May 22, 2026…

  3. TOOL · CL_44153 ·

    ST Wentai sues Anshi Holdings for 8 billion RMB over alleged discriminatory measures

    ST Wentai has filed a lawsuit against Anshi Holdings and others, seeking approximately 8 billion RMB in damages. The company alleges that the defendants unlawfully executed or assisted in discriminatory restrictive meas…

  4. TOOL · CL_22793 ·

    36Kr reports on Bu Chang Pharmaceutical's subsidiary joining AIDS vaccine research

    Bu Chang Pharmaceutical's subsidiary, Zhejiang Tianyuan, has been selected to participate in a national science and technology major project focused on developing an AIDS vaccine. The project involves the production and…